Apidra, solution injectable

7680570130029 CH-57013 Injektionslösung
Apidra, solution injectable
Apidra, solution injectable
1 / 2
google

Article details

Package size
5 x 3
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/06/2024
Patient information leaflet
Français
18/06/2024
Patient information leaflet
Italien
18/06/2024
Summary of Product Characteristics
Allemand
18/06/2024
Summary of Product Characteristics
Français
18/06/2024
Summary of Product Characteristics
Italien
18/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
3.49 MG Substance Wirkstoff (Principe actif)
(N/A)
100.0 U Substance WIIS
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.97 MG Substance HBESI

Reimbursement information

Public price
CHF 56.95
Specialties list
Yes
Generic
No
SL addition date: 01/09/2005

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
57013
Drug name
Apidra, solution injectable
Galenic form
LSPA
ATC Code
A10AB06
Authorization status
Z
Dispensing category
B
First authorization
02/05/2005
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus bei Erwachsenen

Package details

Description (FR)
APIDRA sol inj AllStar Pro/JuniorStar 5 x 3 ml
Description (DE)
APIDRA Inj Lös AllStar Pro/JuniorStar 5 x 3 ml
Market launch
02/05/2005
Narcotic (BTM)
No

Other package sizes (2)

APIDRA sol inj flac 10 ml
1 x 10 ML
GTIN: 7680570130043
View
None
1 x 3 ML
GTIN: None
Not in V1